This review describes and explains various classes of MASI pertaining to oncogenes and their significance in tumorigenesis.
MASI at the EGFR and KRAS loci and their impacts on tumorigenesis and profound clinical implications are highlighted.
The putative tumor-suppressive role of the wild-type KRAS allele in the context of the oncogenic KRAS allele is discussed.